News Release

Mary Ann Liebert names Marianne Russell CEO and President of Mary Ann Liebert, Inc.

Business Announcement

Mary Ann Liebert, Inc./Genetic Engineering News

Mary Ann Liebert, Inc., publishers has named Marianne Russell CEO and President of the company, inclusive of its journals, Genetic Engineering & Biotechnology News (GEN), and Inside Precision Medicine. Mary Ann Liebert will assume the role of Founder and Chair of the company, enabling her to focus on new avenues for strategic growth and investment for the company, which has been her passion from the day the company was founded. This structure also reaffirms the company’s long-standing commitment to remain fully independent and a leading publisher of scientific, technical, and medical content. 

“Marianne Russell and I have worked together for nearly 15 years, and we share a robust vision for the company’s future,” said Liebert. “We are relentless in our mission: the content we publish benefits the research, clinical, and related business communities around the world. It matters and it makes a difference.”

Marianne Russell joined the company as Senior Vice President, Business Development in 2007 and assumed the roles of President of GEN and Chief Operating Officer in 2017. In these roles, Russell led the company to impressive growth through global licensing expansion, high-profile journal acquisitions, society partnerships, and introduction of impactful new digital products and services. She oversaw the doubling of the GEN media brand’s revenue as well as reconceived and relaunched its sister publication Inside Precision Medicine. 

“I am honored to work with incredibly talented teams and committed to ensuring that our products and services are integral to advancing science and improving health outcomes on a global basis,” said Russell.

About the Company
Mary Ann Liebert, Inc. is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines. The company publishes over 100 peer-reviewed journals, leading trade magazines, and specialized newsletters.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.